Mounjaro is a dual GIP and GLP-1 receptor agonist
Hypoxia-inducible factor-1: a novel therapeutic target for the management of cancer, drug resistance, and cancer-related pain
PM: Validation, Supervision, Visualization, Writing review & editing
Key target genes include those encoding components of the electron transport chain (ATP synthase subunits, cytochrome c), fatty acid oxidation enzymes (medium-chain acyl-CoA dehydrogenase, carnitine palmitoyltransferase 1), and transcription factors that amplify the metabolic signal (PGC-1 itself, NRF-1)
At our medical weight loss clinic Waxahachie residents can access, effective treatments include prescription weight loss programs designed for lasting results
Probiotics do not create safety concerns in this context and may improve GI tolerability during the initial berberine adaptation period